Heron Therapeutics Earning Date (HRTX)

USA |NASDAQ |USD

HRTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 22, 2022 Dec 2021 $-0.58 $-0.51 $-0.68
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 22, 2022 Dec 2021 $25.59M $23.23M $20.61M

Heron Therapeutics's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 2021.

HRTX Earnings Date & History Chart

HRTX Earnings & Revenue Forecast

HRTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.58 $-0.62 $-0.51
Mar 2022 1 $-0.45 $-0.45 $-0.45
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-2.28 $-2.33 $-2.21
Dec 2022 6 $-1.97 $-2.26 $-1.42

HRTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 3 / 0 $-0.60 $-0.60 $-0.63
Mar 2022 0 / 0 $-0.26 $-0.26 $-0.22
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 5 / 0 $-2.40 $-2.40 $-2.44
Dec 2022 1 / 1 $-1.64 $-1.64 $-1.62

HRTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $25.59M $24.00M $27.37M
Mar 2022 1 $35.96M $35.96M $35.96M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $91.24M $89.69M $93.06M
Dec 2022 5 $149.51M $125.00M $172.30M

HRTX Earnings Date & Revenue History

HRTX Earnings History

|
Show More
Show More

HRTX Revenue History

|
Show More
Show More

Heron Therapeutics Next Earnings Date & Report

HRTX Next Earnings Date & Report Preview: Dec 2021 (FQ)

HRTX's next earnings date is Tuesday, Feb 22, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 5 analysts, the average EPS estimation for Heron Therapeutics's next quarterly earnings is $-0.58, with a low EPS estimation of $-0.62, and a high estimation of $-0.51.

Over the last 1 month, EPS estimates have seen 3 upward revisions and 0 downward. The EPS 1 month trend is $-0.60, the last 2 month trend is $-0.60, and the 3 month trend is $-0.63.

Based on 5 analysts, the average revenue estimation is $25.59M, with a low revenue estimation of $24.00M, and a high estimation of $27.37M.

Heron Therapeutics Previous Earnings Dates & Reports

HRTX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Heron Therapeutics's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.

HRTX's earnings per share (EPS) was $-0.51, beating the consensus analysts forecast of $-0.60 by 14.53%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -17.74%, and higher than the same period a year before (Sep 2020) by -20.31%.

Revenues were $23.23M, worse than the forecast of $25.51M by -8.94%, up by 3.51% from the previous quarter , and up by 16.35% from the same period last year.

The company reported a net income of $-52.41M.

Free cash flow for the quarter was $-54.70M , compared to $-63.31M last quarter and $-42.69M a year before.

HRTX ended the quarter with $164.50M in total debt, a decrease of -0.40% compared to the previous quarter, and an increase of 562.05% compared to the same quarter a year before.

HRTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Heron Therapeutics's previous annual earnings date was Feb 24, 2021 for its fiscal year ended Dec 31, 2020.

HRTX's earnings per share (EPS) was $-2.50, missing the consensus analysts forecast of $-2.47 by 1.21% , and higher than the previous year's EPS (Dec 2019) by 0.00%.

Revenues were $88.64M, better than the forecast of $87.19M by 1.66%, and down by -39.28% from previous year's revenue.

The company reported a net income of $-227.28M.

Heron Therapeutics reported a free cash flow of $-191.63M for its fiscal year, compared to $-131.73M a year ago.

The company ended the fiscal year with $24.61M in total debt, an increase of 24.35% compared to the previous year.